PROspective Renal Cancer Cohort (PRO-RCC)
Status: Recruiting
Location: See all (27) locations...
Study Type: Observational
SUMMARY
PRO-RCC is a nationwide long-term cohort for the collection of real-world clinical data, patient reported outcome measures (PROMs) and patient reported experience measures (PREMs) that provides an infrastructure for observational research and (randomized) interventional studies with the TwiCs (Trial within cohorts) design.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• newly diagnosed patients with RCC or synchronous metastatic RCC
• metachronous metastasized RCC
• age \>18 years
• capable of understanding Dutch language
Locations
Other Locations
Netherlands
Jeroen Bosch Ziekenhuis
RECRUITING
's-hertogenbosch
Jeroen Bosch Ziekenhuis
RECRUITING
's-hertogenbosch
Meander Medisch Centrum
RECRUITING
Amersfoort
Amsterdam UMC locatie VUMC
RECRUITING
Amsterdam
Gelre ziekenhuis
RECRUITING
Apeldoorn
Rijnstate
RECRUITING
Arnhem
Amphia Ziekenhuis
RECRUITING
Breda
Deventer Ziekenhuis
RECRUITING
Deventer
Albert Schweitzer
RECRUITING
Dordrecht
Catharina ziekenhuis
RECRUITING
Eindhoven
Maxima MC
RECRUITING
Eindhoven
Treant
RECRUITING
Emmen
UMCG
RECRUITING
Groningen
Spaarne Gasthuis
RECRUITING
Haarlem
Tergooi MC
RECRUITING
Hilversum
Medisch Centrum Leeuwarden
RECRUITING
Leeuwarden
Maastricht UMC
RECRUITING
Maastricht
St Antonius Ziekenhuis
RECRUITING
Nieuwegein
Canisius Wilhelmina Ziekenhuis
RECRUITING
Nijmegen
Bravis ziekenhuis
RECRUITING
Roosendaal
Erasmus MC
RECRUITING
Rotterdam
Maasstad ziekenhuis
RECRUITING
Rotterdam
St. Franciscus ziekenhuis
RECRUITING
Rotterdam
Haaglanden Medisch Centrum
RECRUITING
The Hague
UMC Utrecht
RECRUITING
Utrecht
Viecuri
RECRUITING
Venray
Isala
RECRUITING
Zwolle
Contact Information
Primary
Hilin Yildirim, MD
h.yildirim@iknl.nl
0031643202583
Time Frame
Start Date: 2023-01-19
Estimated Completion Date: 2030-01
Participants
Target number of participants: 2000
Treatments
localized RCC
all patients with localized RCC
metastatic RCC
all patients with metastatic RCC, synchronous or metachronous
Related Therapeutic Areas
Sponsors
Collaborators: Bristol-Myers Squibb, Ipsen, Merck Sharp & Dohme LLC, Comprehensive Cancer Centre The Netherlands, Pfizer
Leads: PROspective Renal Cancer Cohort Foundation